Tuesday, 02 January 2024 12:17 GMT

Medicenna Therapeutics Corp.


(MENAFN- Baystreet) 09:44 AM EST - Medicenna Therapeutics Corp. : Announced today that Dr. Fahar Merchant, President and CEO of Medicenna, will participate in the ROTH 4th Annual Healthcare Opportunities Conference, taking place at the Metropolitan Club in New York City on October 8-9. Medicenna Therapeutics Corp. shares T are trading unchanged at $0.98.

MENAFN01102025000212011056ID1110137323



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search